The Top Line
By Fierce Life Sciences
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Fierce Life Sciences
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 19
Reviews: 0
Episodes: 100
Description
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
| Episode | Date |
|---|---|
|
Winning formulas for the best biotech and drug names
|
Apr 19, 2024 |
|
[Sponsored] What does the future of specialist distribution look like?
|
Apr 15, 2024 |
|
Deep dive: Biopharma layoffs in Q1
|
Apr 12, 2024 |
|
The unrecognized threat of PAD
|
Apr 05, 2024 |
|
The top money raisers in biotech
|
Mar 29, 2024 |
|
A closer look at European biotech investment in 2024
|
Mar 22, 2024 |
|
Inclusivity in psoriasis trials with Takeda
|
Mar 15, 2024 |
|
Fierce Medtech's Fierce 15
|
Mar 08, 2024 |
|
[Sponsored] A Person-Centered Approach to Achieving Long-Term Success
|
Mar 04, 2024 |
|
CAR-T boxed warnings: What comes next?
|
Mar 01, 2024 |
|
Breaking down Eli Lilly’s ESG formula
|
Feb 23, 2024 |
|
Gene editing's next act
|
Feb 16, 2024 |
|
The most anticipated drug launches of 2024
|
Feb 09, 2024 |
|
[Sponsored] Turning information into outcomes with MedThink Communications
|
Feb 05, 2024 |
|
[Sponsored] Talking technology and collaboration with Cytiva
|
Feb 05, 2024 |
|
Navigating the future of medical AI
|
Feb 02, 2024 |
|
Closing the $1 trillion women’s health gap
|
Jan 26, 2024 |
|
A closer look at the bounty of new drug approvals in 2023
|
Jan 19, 2024 |
|
The year in biotech
|
Dec 22, 2023 |
|
[Sponsored] Addressing the evolving needs of pharma for CDx development
|
Dec 20, 2023 |
|
A closer look at the Fierce 50
|
Dec 15, 2023 |
|
Turning down the toxicity of nature’s most powerful antifungal
|
Dec 08, 2023 |
|
Fiercest Women in Life Sciences, meet the Fierce 50
|
Dec 01, 2023 |
|
Exploring Alzheimer’s breakthroughs, Leqembi's potential and what comes next
|
Nov 17, 2023 |
|
A look at psychedelics and the next frontier of mental healthcare
|
Nov 10, 2023 |
|
Exploring the promise of earlier Alzheimer's treatment
|
Nov 03, 2023 |
|
A look at the FDA's Aduhelm approval and the potential for regulatory bias
|
Oct 27, 2023 |
|
Leqembi's full approval and the future of Alzheimer's treatment
|
Oct 20, 2023 |
|
Unraveling Alzheimer's disease treatments and a look ahead
|
Oct 13, 2023 |
|
[Sponsored] Modeling patient insights to make the most of clinical trials
|
Oct 05, 2023 |
|
Opportunities, challenges and uncharted territory in pharma marketing
|
Oct 05, 2023 |
|
Exploring AstraZeneca's environmental pledges
|
Sep 29, 2023 |
|
Fierce Biotech's Fierce 15, plus a deep dive into drug commercialization strategies
|
Sep 22, 2023 |
|
[SPONSORED] Accelerate and Optimize Rare Disease Patient-Finding with AI
|
Aug 28, 2023 |
|
August 18, 2023
|
Aug 18, 2023 |
|
August 11, 2023
|
Aug 11, 2023 |
|
August 4, 2023
|
Aug 04, 2023 |
|
July 28, 2023
|
Jul 28, 2023 |
|
July 21, 2023
|
Jul 21, 2023 |
|
July 14, 2023
|
Jul 14, 2023 |
|
[Sponsored] Clinical trial technologies support recruitment efforts
|
Jul 10, 2023 |
|
July 7, 2023
|
Jul 07, 2023 |
|
June 30, 2023
|
Jun 30, 2023 |
|
June 23, 2023
|
Jun 23, 2023 |
|
June 16, 2023
|
Jun 16, 2023 |
|
June 9, 2023
|
Jun 09, 2023 |
|
[Sponsored] Addressing the patient centricity challenge with ZS Associates
|
Jun 02, 2023 |
|
June 2, 2023
|
Jun 02, 2023 |
|
May 26, 2023
|
May 26, 2023 |
|
May 19, 2023
|
May 19, 2023 |
|
May 12, 2023
|
May 12, 2023 |
|
[Sponsored] Inside Abbott’s beating heart of electrophysiology innovation
|
May 08, 2023 |
|
May 5, 2023
|
May 05, 2023 |
|
April 27, 2023
|
Apr 28, 2023 |
|
April 21, 2023
|
Apr 21, 2023 |
|
April 14, 2023
|
Apr 14, 2023 |
|
April 7, 2023
|
Apr 07, 2023 |
|
March 31, 2023
|
Mar 31, 2023 |
|
March 24, 2023
|
Mar 24, 2023 |
|
[Sponsored] Is your biotech ready for 2023? MacDougall Advisors has insight
|
Mar 19, 2023 |
|
March 17, 2023
|
Mar 17, 2023 |
|
March 10, 2023
|
Mar 10, 2023 |
|
March 3, 2023
|
Mar 03, 2023 |
|
February 24, 2023
|
Feb 24, 2023 |
|
February 17, 2023
|
Feb 17, 2023 |
|
[Sponsored] New Era in Biologically Targeted Radiotherapy to Combat Cancer
|
Feb 13, 2023 |
|
February 10, 2023
|
Feb 10, 2023 |
|
February 3, 2023
|
Feb 03, 2023 |
|
January 27, 2023
|
Jan 27, 2023 |
|
January 20, 2023
|
Jan 20, 2023 |
|
January 13, 2022
|
Jan 13, 2023 |
|
January 6, 2022
|
Jan 06, 2023 |
|
December 16, 2022
|
Dec 16, 2022 |
|
December 9, 2022
|
Dec 09, 2022 |
|
December 2, 2022
|
Dec 02, 2022 |
|
[Sponsored] Slope’s Hope Meely on the importance of a fully enabled clinical supply platform
|
Nov 28, 2022 |
|
November 18, 2022
|
Nov 18, 2022 |
|
November 11, 2022
|
Nov 11, 2022 |
|
November 4, 2022
|
Nov 04, 2022 |
|
October 28, 2022
|
Oct 28, 2022 |
|
October 19, 2022
|
Oct 21, 2022 |
|
October 14, 2022
|
Oct 14, 2022 |
|
October 6, 2022
|
Oct 07, 2022 |
|
September 30, 2022
|
Sep 30, 2022 |
|
September 23, 2022
|
Sep 23, 2022 |
|
September 16, 2022
|
Sep 16, 2022 |
|
September 9, 2022
|
Sep 09, 2022 |
|
September 2, 2022
|
Sep 02, 2022 |
|
August 26, 2022
|
Aug 26, 2022 |
|
August 19, 2022
|
Aug 19, 2022 |
|
August 12, 2022
|
Aug 12, 2022 |
|
August 5, 2022
|
Aug 05, 2022 |
|
July 29, 2022
|
Jul 29, 2022 |
|
July 22, 2022
|
Jul 22, 2022 |
|
July 15, 2022
|
Jul 15, 2022 |
|
July 8, 2022
|
Jul 08, 2022 |
|
July 1, 2022
|
Jul 01, 2022 |
|
June 24, 2022
|
Jun 24, 2022 |
|
June 17, 2022
|
Jun 17, 2022 |
|
June 10, 2022
|
Jun 10, 2022 |